Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

GCTK stock hub

GlucoTrack, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GCTKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GCTK

In the news

Latest news · GCTK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROEn/a

P25 -106.6P50 -46.9P75 -3.1

ROICn/a

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GCTK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001506983
Company name	GlucoTrack, Inc.
Country	United States
Country code	US
Cusip	45824Q804
Employees	15
Employees Change	4%
Employees Change Percent	36.36
Enterprise value	$-1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Isin	US45824Q8042
Last refreshed	2026-05-10
Market cap	$2.9M
Market cap category	Nano-Cap
Price	$0.8
Price currency	USD
Sector	Healthcare
Sic	3841
Symbol	GCTK
Website	https://glucotrack.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-661.96%
FCF yield	-523.61%
P/B ratio	0.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19.4M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	$-1.3M
ROA	-146.1
Roa5y	-105.7
ROCE	-525

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-72.4%
Cagr1y	-92.14%
Cagr3y	-93.56%
Cagr5y	-87.38%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$7.8M
Cash	$7.4M
Current Assets	$7.7M
Current Liabilities	$4.8M
Debt	$3.4M
Debt Equity	$1.22
Equity	$2.8M
Interest Coverage	-282.3
Liabilities	$5M
Long Term Assets	$171,000
Long Term Liabilities	$237,000
Net Cash	$3.9M
Net Cash By Market Cap	$134
Net Cash Growth	-26.41%
Net Debt Equity	$-1.39
Tangible Book Value	$2.8M
Tangible Book Value Per Share	$3.11
WACC	4.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.61
Net Working Capital	$-1.3M
Quick ratio	1.55
Working Capital	$2.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-92.13%
200-day SMA	4.08
3Y total return	-99.97%
50-day SMA	0.97
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	780,000.8
All Time High Change	-100%
All Time High Date	2013-05-13
All Time Low	0.62
All Time Low Change	29.31%
All Time Low Date	2026-03-31
ATR	0.16
Beta	0.77
Beta1y	2.81
Beta2y	2.92
Ch YTD	-79.32
High	0.85
High52	15.9
High52 Date	2025-06-25
High52ch	-94.97%
Low	0.76
Low52	0.62
Low52 Date	2026-03-31
Low52ch	29.31%
Ma50ch	-17.79%
Premarket Change Percent	-2.29
Premarket Price	$0.84
Premarket Volume	201,280
Price vs 200-day SMA	-80.36%
RSI	46.1
RSI Monthly	32.2
RSI Weekly	29.38
Sharpe ratio	-0.72x
Sortino ratio	-1.28
Tr YTD	-79.32
Tr1m	17.22%
Tr1w	0.05%
Tr3m	-54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-16.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,600,857%
Float Percent	98.4%
Net Borrowing	3,000,000
Shares Insiders	0.35%
Shares Institutions	4.94%
Shares Out	3,659,279
Shares Qo Q	1.5%
Short Float	18.62%
Short Ratio	0.22
Short Shares	18.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-15.7M
Average Volume	12,276,581.8x
Bv Per Share	3.11
CAPEX	$-96,000
Ch10y	-100
Ch1m	17.22
Ch1w	0.05
Ch1y	-92.13
Ch3m	-54
Ch3y	-99.97
Ch5y	-100
Ch6m	-85.66
Change	-6.93%
Change From Open	-3.88
Close	0.86
Days Gap	-3.17
Depreciation Amortization	42,000
Dollar Volume	1,250,289.6
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-16.1M
EBITDA	$-16M
EPS	$-31.22
F Score	1
FCF	$-15.3M
FCF EV Yield	1,521.26x
FCF Per Share	$-4.19
Financing CF	17,043,000
Fiscal Year End	December
Founded	2,001
Investing CF	-96,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2025-06-16
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	3.45
Ma150ch	-76.79%
Ma20	0.79
Ma20ch	1.75%
Net CF	1,756,000
Next Earnings Date	2026-05-22
Open	0.83
Optionable	No
Position In Range	44.89
Post Close	0.8
Postmarket Change Percent	-1.3
Postmarket Price	$0.79
Ppne	171,000
Pre Close	0.86
Price Date	2026-05-08
Ptbv Ratio	1.04
Relative Volume	0.13x
Share Based Comp	333,000
Tr6m	-85.66%
Us State	New Jersey
Volume	1,562,081

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GCTK pay a dividend?

Capital-return profile for this ticker.

Performance

GCTK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GCTK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.9%

Float: +98.4% of shares outstanding

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GCTK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

-80.4%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

-0.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GCTK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GCTK stock rating?

GlucoTrack, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GCTK analysis?

The full report lives at /stocks/GCTK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GCTK?

The latest report frames GCTK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GCTK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.